FDA Adverse Event Injury Summary report: N

ANIMAS INSULIN CARTRIDGE

MDR report key: 5138025 · Received October 8, 2015

Report

Report Number
2531779-2015-36270
Event Type
Injury
Date Received
October 8, 2015
Date of Event
September 20, 2015
Report Date
September 21, 2015
Manufacturer
ANIMAS CORPORATION
Product Code
LZG
PMA / PMN Number
K032257
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NJ, US
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

THE CARTRIDGE HAS NOT BEEN RETURNED TO ANIMAS. IF THE DEVICE IS RETURNED, AN EVALUATION SHALL BE COMPLETED AND A SUPPLEMENTAL REPORT WILL BE FILED. NO CONCLUSIONS CAN BE MADE AT THIS TIME.

Additional Manufacturer Narrative · 1

FOLLOW-UP #2 DATE OF SUBMISSION 12/14/2015-DEVICE EVALUATION: THE REPORTER STATED THAT THE ALLEGED ISSUE OCCURRED WITH EITHER CARTRIDGE LOT # D200169 OR WITH CARTRIDGE LOT # D200173. AS THE REPORTER WAS UNSURE WHICH LOT # THE ALLEGED ISSUE OCCURRED WITH, CARTRIDGES FROM BOTH LOT #S WERE RETURNED. ADDITIONAL RETURNED CARTRIDGES WERE EVALUATED BY PRODUCT ANALYSIS ON 11/20/2015 WITH THE FOLLOWING FINDINGS: A VISUAL INSPECTION OF THE CARTRIDGES WAS PERFORMED. NO DAMAGE OR DEFECTS WERE NOTED. A LEAK TEST, FORCE TEST, AND FILL TEST WAS PERFORMED WITH NO FAILURES OBSERVED. EACH CARTRIDGE LOT IS SUBJECTED TO A STATISTICAL SAMPLING PLAN AND MUST PASS TESTING FOR FORCE (OCCLUSION AND LOSS OF PRIME), CRACKS, AND FOREIGN MATERIAL PRIOR TO RELEASE FOR DISTRIBUTION.

Additional Manufacturer Narrative · 1

FOLLOW-UP #1 DATE OF SUBMISSION 11/02/2015-DEVICE EVALUATION: THE CARTRIDGE HAS BEEN RETURNED AND EVALUATED BY PRODUCT ANALYSIS ON (B)(4) 2015 WITH THE FOLLOWING FINDINGS: SIX UNOPENED CARTRIDGES AND ONE OPENED CARTRIDGE WERE RETURNED. A VISUAL INSPECTION OF THE CARTRIDGES WAS PERFORMED. NO DAMAGE OR DEFECTS WERE NOTED. A LEAK TEST, FORCE TEST, AND FILL TEST WAS PERFORMED WITH NO FAILURES OBSERVED. A RETAIN CARTRIDGE SAMPLE FROM THE SAME LOT WAS ALSO TESTING WITH NO FAILURES FOUND. EACH CARTRIDGE LOT IS SUBJECTED TO A STATISTICAL SAMPLING PLAN AND MUST PASS TESTING FOR FORCE (OCCLUSION AND LOSS OF PRIME), CRACKS, AND FOREIGN MATERIAL PRIOR TO RELEASE FOR DISTRIBUTION.

Description of Event or Problem · 1

ON (B)(4) 2015, THE REPORTER CONTACTED ANIMAS ALLEGING THAT ON (B)(6) 2015 THE PATIENT EXPERIENCED ELEVATED BLOOD GLUCOSE (BG) GREATER THAN 600MG/DL WITH CHEST PAIN, NECK AND SHOULDER PAIN, VOMITING, NAUSEA, EXTREME THIRST, EXCESS URINATION, AND LARGE KETONES. THE PATIENT WAS REPORTEDLY HOSPITALIZED AND TREATED WITH IV FLUIDS, INSULIN INJECTIONS, AND INSULIN VIA THE PUMP. THE REPORTER STATED THAT THE PATIENT FILLED A CARTRIDGE ON (B)(6) 2015, AND WHEN THE PATIENT WAS ADMITTED TO THE HOSPITAL THE FOLLOWING DAY THE HEALTHCARE PROVIDER REMOVED THE CARTRIDGE FROM THE PUMP AND FOUND THAT THERE WAS NO INSULIN IN THE CARTRIDGE. THERE WAS NO ALLEGATION OF POWER LOSS. THE PUMP REPORTEDLY WAS GIVING A REMAINING INSULIN READING OF 106 UNITS AT THE TIME THE CARTRIDGE WAS DISCOVERED TO BE EMPTY. THE ISSUE REPORTEDLY OCCURRED WITH ONE CARTRIDGE. THE PATIENT'S HEALTHCARE PROVIDER INSISTED THAT THE CARTRIDGE BE REPLACED. THIS COMPLAINT IS BEING REPORTED BASED ON THE ALLEGATION THAT THE PATIENT EXPERIENCED SEVERED HYPERGLYCEMIA ASSOCIATED WITH A CARTRIDGE ISSUE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
668677 ANIMAS INSULIN CARTRIDGE INSULIN INFUSION PUMP LZG ANIMAS CORPORATION D200173

Patients

Seq Age Sex Outcome Treatment
1 18 YR Hospitalization| L| R